U.S. Therapeutic Monoclonal Antibodies Markets
25-May-2005
North America
Market Research
F337-01-00-00-00
HC01446-NA-MR_05925
The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.
Executive Summary
- Executive Summary
Objectives and Scope
- Objectives
- Scope
Monoclonal Antibodies Market Overview
- Introduction
- Structure of Antibodies
- Typical Problems with Murine mAbs
- The Role of Hybridoma Clone
- Medical Utility of mAbs
- Market Overview
Evolution and Technology Trends
- Introduction
- Early Murine mAbs
- Chimeric mAbs
- Humanized mAbs
- Fully Human mAbs
- Phage Display of Human mAbs
- Monoclonal Antibodies as Carriers
- Naked Monoclonal Antibodies
- Conjugated Monoclonal Antibodies
Future of Monoclonal Antibodies
- The Foundation for Optimistic Future
- Return on Investment and Future
Challenges Affecting the US Therapeutic Monoclonal Antibodies Market
Overview of the mAbs Pipeline
Market Dynamics
Market Forecasts
Frost and Sullivan Awards
- Introduction
- Market Engineering Measurement
- Market Drivers
- Market Restraints
Competitive Structure
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Strategic Recommendations
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplant Databases
Cardiovascular Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.